Concert Pharmaceuticals

Sun Pharma to purchase Concert Pharmaceuticals for $576M

Medical Marketing and Media

Thu, 01/19/23 - 10:51 am

Sun Pharma

M&A

deuterium

Concert to seek approval for hair loss drug after second study success

BioPharma Dive

Mon, 08/1/22 - 10:49 am

Chasing Lilly and Pfizer, Concert's JAK inhibitor hits high notes in phase 3 alopecia trial

Fierce Biotech

Mon, 05/23/22 - 10:36 am

With a make-or-break PhIII readout looming, a struggling Concert offloads a 'portfolio' of drugs

Endpoints

Mon, 03/14/22 - 10:31 am

Terran Biosciences

CNS

schizophrenia

Chasing Lilly, Concert eyes 2023 filing for its JAK drug for alopecia

Pharmaforum

Fri, 05/28/21 - 11:10 am

alopecia

Concert dumps schizophrenia drug CTP-692 after failing phase 2

Fierce Biotech

Mon, 02/1/21 - 10:56 am

CTP-692

Concert gets BTD for alopecia drug, setting up a late-stage showdown with giant rival Pfizer

schizophrenia

Endpoints

Wed, 07/8/20 - 10:45 am

alopecia areata

FDA

breakthrough therapies

With FDA’s Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss

Xconomy

Tue, 09/3/19 - 10:28 am

The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs

Yahoo/Benzinga

Mon, 04/22/19 - 10:34 am

Precision Biosciences

Concert’s initial alopecia data fall short against Pfizer, prompting investor blow back

Endpoints

Tue, 11/13/18 - 09:50 am

Concert rethinks R&D plans after loss in Incyte patent case

Fierce Biotech

Fri, 01/12/18 - 06:40 pm

After a quick trial revamp, FDA lifts its clinical hold on Concert’s hair-loss drug

Endpoints

Mon, 07/10/17 - 09:24 am

FDA

FDA forces Concert Pharma to hit the brakes on a mid-stage study so it can review tox studies

alopecia areata

hair loss

Endpoints

Wed, 05/17/17 - 09:34 am

FDA

alopecia areata

A Review Of Concert's Filed PRE 14A: The CTP-656 Saga May Not Be Done Yet

Seeking Alpha

Sun, 03/26/17 - 11:59 am

CTP-656

cystic fibrosis

Kalydeco

Vertex Pharmaceuticals

Concert rebuffed $250M buyout offer from Vertex before CF drug deal

Bizjournals.com

Sat, 03/25/17 - 11:56 am

Vertex Pharmaceuticals

Vertex Pharma Acquires Long-Acting Version of Cystic Fibrosis Drug From Concert Pharma

TheStreet.com

Mon, 03/6/17 - 09:54 am

Vertex Pharma

cystic fibrosis

CTP-656

Kalydeco

10 Best Nasdaq Biotech Stocks in the Third Quarter

TheStreet.com

Wed, 09/30/15 - 07:49 pm

The Medicines Company

Lexicon Pharmaceuticals

Exelixis

Anacor

Concert Pharma's CF drug tops Vertex's top-seller in early study

Fierce Biotech

Thu, 09/24/15 - 07:09 pm